Literature DB >> 32548695

[Perioperative enhanced recovery after surgery program for Ivor Lewis esophagectomy : First experiences of a high-volume center].

C Mallmann1, H Drinhaus2, H Fuchs1, L M Schiffmann1, C Cleff2, E Schönau3, C J Bruns1, T Annecke2, W Schröder4.   

Abstract

BACKGROUND AND
OBJECTIVE: Transthoracic esophagectomy is generally accepted as the standard of surgical care for patients with esophageal cancer. Despite improvements in the perioperative management this surgical procedure is associated with a clinically relevant morbidity. Fast-track protocols (synonym: enhanced recovery after surgery, ERAS) are conceived to perioperatively maintain the physiological homoeostasis and thereby to accelerate postoperative rehabilitation and reduce morbidity. In this prospective observational study the initial experiences of a high-volume center with the implementation of an ERAS protocol after transthoracic esophagectomy were analyzed.
MATERIAL AND METHODS: A total of 26 patients with esophageal cancer and a low index of comorbidities prior to hybrid Ivor Lewis esophagectomy were included in this study. According to an ERAS protocol all patients underwent a standardized perioperative treatment pathway aiming to discharge the patients from the inpatient treatment on postoperative day 10. The primary outcome parameter was the rate of major complications (Clavien-Dindo IIIb/IV), which was compared to a cohort of 52 non-ERAS patients. RESULTS AND
CONCLUSION: The ERAS programs with the various core elements can be implemented in patients scheduled for transthoracic esophagectomy, although the organizational and personnel expenditure of this fast-track protocol is high. The length of hospital stay appears to be reduced without compromising patient safety. The limiting variable of the ERAS protocol remains the early and adequate enteral feeding load of the gastric conduit before discharge on postoperative day 10.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; Fast-track surgery; Perioperative management; Postoperative morbidity

Mesh:

Year:  2021        PMID: 32548695     DOI: 10.1007/s00104-020-01216-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  26 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

Review 2.  Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines.

Authors:  John M Findlay; Richard S Gillies; Julian Millo; Bruno Sgromo; Robert E K Marshall; Nicholas D Maynard
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

Review 3.  [Perioperative management of transthoracic oesophagectomies : Fundamentals of interdisciplinary care and new approaches to accelerated recovery after surgery].

Authors:  R Lambertz; H Drinhaus; D Schedler; M Bludau; W Schröder; T Annecke
Journal:  Anaesthesist       Date:  2016-06       Impact factor: 1.041

Review 4.  Surgical techniques to prevent delayed gastric emptying after esophagectomy with gastric interposition: a systematic review.

Authors:  Ronald D L Akkerman; Leonie Haverkamp; Richard van Hillegersberg; Jelle P Ruurda
Journal:  Ann Thorac Surg       Date:  2014-08-22       Impact factor: 4.330

5.  Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Ralf D Hofheinz; Claudia Pauligk; Hans-Georg Kopp; Georg Martin Haag; Kim Barbara Luley; Johannes Meiler; Nils Homann; Sylvie Lorenzen; Harald Schmalenberg; Stephan Probst; Michael Koenigsmann; Matthias Egger; Nicole Prasnikar; Karel Caca; Jörg Trojan; Uwe M Martens; Andreas Block; Wolfgang Fischbach; Rolf Mahlberg; Michael Clemens; Gerald Illerhaus; Katja Zirlik; Dirk M Behringer; Wolff Schmiegel; Michael Pohl; Michael Heike; Ulrich Ronellenfitsch; Martin Schuler; Wolf O Bechstein; Alfred Königsrainer; Timo Gaiser; Peter Schirmacher; Wael Hozaeel; Alexander Reichart; Thorsten O Goetze; Mark Sievert; Elke Jäger; Stefan Mönig; Andrea Tannapfel
Journal:  Lancet Oncol       Date:  2016-10-22       Impact factor: 41.316

6.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

7.  Risk factors for delayed gastric emptying after esophagectomy.

Authors:  Frank Benedix; Tobias Willems; Siegfried Kropf; Daniel Schubert; Patrick Stübs; Stephanie Wolff
Journal:  Langenbecks Arch Surg       Date:  2017-03-21       Impact factor: 3.445

8.  Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.

Authors:  Jessie A Elliott; Suzanne L Doyle; Conor F Murphy; Sinead King; Emer M Guinan; Peter Beddy; Narayanasamy Ravi; John V Reynolds
Journal:  Ann Surg       Date:  2017-11       Impact factor: 12.969

9.  Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer.

Authors:  Lantao Chen; Lixin Sun; Yaoguo Lang; Jun Wu; Lei Yao; Jinfeng Ning; Jinfeng Zhang; Shidong Xu
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

Review 10.  Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer.

Authors:  E Booka; H Takeuchi; K Suda; K Fukuda; R Nakamura; N Wada; H Kawakubo; Y Kitagawa
Journal:  BJS Open       Date:  2018-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.